# Stroke Minimization Through Additive Anti-atherosclerotic Agents in Routine Treatment

Study · id `cardio:ct-nct03329599` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03329599](<https://clinicaltrials.gov/study/NCT03329599>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT03329599

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 148 participants.

## Technical summary

Registry record NCT03329599. Randomized; quadruple masking; primary purpose treatment. Start 2019-02-14 (actual); primary completion 2021-12-01 (actual). Results posted on 2023-12-20.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 148 participants (enrolled count; ClinicalTrials.gov record NCT03329599, source copy `cardio:ctgov-nct03329599-2023-12-20`, retrieved 2026-10-31)
- Started: 2019-02-14 (actual) (ClinicalTrials.gov record NCT03329599, source copy `cardio:ctgov-nct03329599-2023-12-20`, retrieved 2026-10-31)
- Primary completion: 2021-12-01 (actual) (ClinicalTrials.gov record NCT03329599, source copy `cardio:ctgov-nct03329599-2023-12-20`, retrieved 2026-10-31)
- Completion: 2022-03-30 (actual) (ClinicalTrials.gov record NCT03329599, source copy `cardio:ctgov-nct03329599-2023-12-20`, retrieved 2026-10-31)
- Results first posted: 2023-12-20 (ClinicalTrials.gov record NCT03329599, source copy `cardio:ctgov-nct03329599-2023-12-20`, retrieved 2026-10-31)
- Countries: Ghana (ClinicalTrials.gov record NCT03329599, source copy `cardio:ctgov-nct03329599-2023-12-20`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03329599-2023-12-20`, retrieved 2026-10-31)

## The registry's words

- Brief title: Stroke Minimization Through Additive Anti-atherosclerotic Agents in Routine Treatment
- Condition: Atherosclerosis
- Condition: Adherence, Medication
- Condition: Tolerance
- Intervention (Drug): Polycap
- Lead sponsor: Northern California Institute of Research and Education
- Lead sponsor class: OTHER
- Collaborator: Kwame Nkrumah University Teaching Hospital
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Atherosclerosis (`cardio:atherosclerosis`)
- Registry lists this organization as the lead sponsor: Northern California Institute of Research and Education (`cardio:org-northern-california-institute-of-research-and-education`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: A cardiovascular polypill for secondary stroke prevention in a tertiary centre in Ghana (SMAART): a phase 2 randomised clinical trial (`cardio:pubmed-37734804`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effect of a Cardiovascular Polypill on Poststroke Cognition Among Ghanaians: Secondary Analysis of a Randomized Clinical Trial (`cardio:pubmed-39082406`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: b14da09d6155f578719a6c062c3c1b92a3fad0257b4425a18533eddf2a52772e
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
